Nephrogen

Nephrogen is a biotech company developing curative gene therapies for kidney diseases.

Health and bioY CombinatorTechstars

Latest funding

Seed · October 6, 2026

Amount not disclosed in a source on record.

Website: nephrogenbiotech.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Healthcare, Therapeutics, Gene Therapy, CRISPR, Biotech.

Stage: Seed.

Based in: New York City, United States.

Last round: Oct 6, 2026 · 37 days ago.

Team: 5 people on the team page.

On Recent Funding since: Sep 28, 2026.

Signals

Website registeredNov 13, 2015 (11 years old)

October 6, 2026
Seed · amount undisclosed
NNational Kidney Foundation (lead)
Source: kidney.org
Summer 2020
YY Combinator · batch
Source: ycombinator.com
November 13, 2015
Website created

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/nephrogen (get a free API key).